Where science is transformative.

Our R&D efforts are focused on four therapeutic areas: Gastrointestinal and Inflammation, Neuroscience, Oncology, and Rare Genetics and Hematology. We also make targeted R&D investments in PDT and Vaccines.

We focus on developing innovative medicines that make a difference in people's lives by advancing the frontier of new treatment options and leveraging our collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline.

Development pipeline by phase and therapeutic area

DOWNLOAD THE PDF

Expected timelines of key development programs

DOWNLOAD THE PDF